Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Am J Transplant. 2010 Mar 23;10(8):1823–1833. doi: 10.1111/j.1600-6143.2010.03046.x
Bulent Degertekin Nothing to disclose
Steven-Huy B. Han Grant support: Gilead, Bristol-Myers Squibb, Roche; Advisory board/consultant: Gilead, Bristol-Myers Squibb, Roche, Schering Plough; Speaker bureau: Gilead, Bristol-Myers Squibb, Roche
Emmet B Keeffe Advisory board/consultant: Abbott Molecular; Speaking and teaching: Bristol-Myers Squibb, Roche Molecular Diagnostics
Eugene R Schiff Grant/research support: Gilead and Bristol Myers Squibb; Scientific Advisory Board: Gilead and Bristol Myers Squibb; Speaker bureau: Bristol-Myers Squibb.
Velimir Luketic Grant support: Schering-Plough, GlaxoSmithKline, Bristol- Myers Squibb, Globimmune, Biolex, ZymoGenetics, Conatus, Vertex, Idenix, Pharmasset, Romark, Human Genome Sciences, Wyeth Ayerst, and Intercept.
Robert S. Brown, Jr. Grant/Research Support; Gilead, Bristol-Myers Squibb; Speaking and Teaching; Gilead.
Sukru Emre- Nothing to disclose
Consuelo Soldevila-Pico Nothing to disclose
K. Rajender Reddy Grant/Research support: GlaxoSmithKline, Schering-Plough, Vertex, Boehringer-Ingelhiem, Gilead; Advisory Board: Gilead, Roche; Schering-Plough, Novartis, Merck.
Michael Ishitani Nothing to disclose
Tram Tran Consultant/Speaker: Gilead Sciences, Bristol Myers Squibb
Timothy Pruett Nothing to disclose
Anna SF Lok Grant/Research Support: Bristol-Myers Squibb, GlaxoSmithKline, Schering-Plough, Roche, Novartis, Gilead, Innogenetics, and Nabi; Consulting: Roche, Gilead, Bristol-Myers Squibb.